Acute cardiac care & resuscitation
ECMO for Drug-Refractory Electrical Storm Without a Reversible Trigger: A Retrospective Multicentric Observational Study
Authors' conclusion
VA-ECMO bridged drug-refractory ES without a reversible trigger with a high success rate.
Study context
- Population
- Drug-refractory electrical storm without a reversible trigger requiring venoarterial extracorporeal membrane oxygenation (VA-ECMO)of 552 VA-ECMO patients
- Participants
- 34 participants
- Outcome
- Outcome on VA-ECMO
Methodological detailsmulticentre, 4 Iberian centres
- Multicentre
- 4 Iberian centres
Main finding
As reported in the abstract
Weaned from VA-ECMO
18
53%
Heart transplantation
29%
Survival to hospital discharge
27
79%
Time to discharge, days
48
33–82
Observational data: associations, not effects.
Further findings
Predictors of death (non-survivors vs survivors)
- Age, years
- 62 (58-67) vs. 54 (43-58); P < 0.01
- First rhythm disorder-to-ECMO interval, days
- 0 (0-2) vs. 2 (1-11); P = 0.02
Follow-up · 29 (12-48) months
- Rehospitalization
- 7 (20%)
- Electrical storm (ES) recurrence
- 6%
Safety
Main complications
- Nosocomial infection
- 47%
- Bleeding
- 24%
- Limb ischaemia
- 21%
Original publication
ECMO for Drug-Refractory Electrical Storm Without a Reversible Trigger: A Retrospective Multicentric Observational Study. ESC Heart Fail. Published 11 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →